AN2 Therapeutics

United States
New Lisbon, Wisconsin, United States

Company profile

AN2 Therapeutics company profile

AN2 Therapeutics, Inc. is a California-based global health biopharmaceutical company focused on modern biomedical and drug development expertise to provide transformational medicines for patients suffering from infectious diseases. The company was founded in 2017 and is headquartered in Menlo Park, California, United States.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
2017-01-01

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
6
Total equity funding
$162M
Last funding
Grant / 2025-11-10
Last equity funding
Post IPO Equity / $70M
Investors
17
Lead investors
3
Founders
4
Articles
72
Exited on
2022-03-25

Founders and investors

Founders

Eric EasomGeorge TalbotJoseph ZakrzewskiMIchael Alley

Lead investors

Bill & Melinda Gates FoundationMountain Group CapitalRA Capital Management

Investors

Bill & Melinda Gates FoundationFrazier Life SciencesJanus Henderson InvestorsRA Capital ManagementTCG Crossover